Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Novo Nordisk is preparing to launch its blockbuster obesity drug Wegovy (injectable semaglutide) in India later this year, ...

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic ...

Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...

Historical trends and future projections of the number of people with overweight and obesity suggest alarming parallel ...

Novo’s stock has fallen over 12% so far this year, while Lilly’s has jumped 8%. The active ingredient in Wegovy is semaglutide, which is likely to go off-patent in 2026 in India. "The dual ...

ASX health stocks broke their losing streak this week, while it was a big week for Nanosonics, Neurizon and Sigma.

Zyxel Networks, a leader in delivering secure, AI- and cloud-powered business and home networking solutions, today extended its family of affordable WiFi 7 access points with the launch of NWA110BE ...